Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unique Therapeutics is a biopharmaceutical company specializing in the development and production of advanced cannabinoid-based formulations using proprietary nanoliposomal delivery systems. The company's platform technology produces nano-emulsions with particle sizes below 50 nm, significantly enhancing the bioavailability, absorption, and stability of active ingredients like cannabidiol (CBD) and tetrahydrocannabinol (THC). Unique Therapeutics collaborates with leading academic institutions and hospitals, such as SRM University and the Superhumans Center in Lviv, to evaluate its formulations for indications including osteoarthritis and post-traumatic stress disorder (PTSD). Its product portfolio includes oral sprays, tinctures, gummies, and topicals designed for precise dosing and rapid onset of action. Through its subsidiary brands like Thronus Medical, the company expands the global reach of its advanced cannabinoid solutions into international prescription markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unique Therapeutics.